StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Investment analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Saturday. The brokerage set a “hold” rating on the stock.

ObsEva Trading Down 15.5 %

Shares of OBSV opened at $0.10 on Friday. The company’s 50 day moving average price is $0.01. ObsEva has a one year low of $0.08 and a one year high of $2.14. The firm has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.